Evidence map›Paper›PMID 36010402›Full record

ArticleFoods (Basel, Switzerland)2022

Characterization of a Nattokinase from the Newly Isolated Bile Salt-Resistant

Yuan Li, Xiyu Tang, Liangqi Chen, Xinran Xu, Jinyao Li

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Safety Evaluation ofFood science & nutrition · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yuan LiInstitute of Materia Medica, Xinjiang University, Urumqi 830017, China.ORCID 0000-0002-4024-6174
Xiyu TangXinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China.
Liangqi ChenXinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China.
Xinran XuXinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China.
Jinyao LiInstitute of Materia Medica, Xinjiang University, Urumqi 830017, China.ORCID 0000-0002-3295-6096
Xinjiang University · CNXinjiang Institute of Materia Medica · CN

Funding

National College Students Innovation Training Program 500122007021The Science and Technology Department of Xinjiang Uygur Autonomous Region 2022D01C96
6 · The paper itself

Abstract

Nattokinase is a potential new thrombolytic drug because of its strong thrombolytic effect, high safety, and low cost. However, there is no research reporting on bile salt-tolerant nattokinase-producing probiotics. In this study, the bile salt-tolerant nattokinase-producing strain

Indexed as

Bacillus nattokinasebioinformatics analysisenzymatic propertiesfermentation processheterologous expressionproductivity analysis

Identifiers

PMID36010402
PMCPMC9407603
OpenAlexW4291670534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.